Risk factors for multidrug resistant tuberculosis in Europe: a systematic review

Faustinu, A.; Hall, A. J.; Perucci, C. A.
February 2006
Thorax;Feb2006, Vol. 61 Issue 2, p158
Academic Journal
Background: The resurgence of tuberculosis (TB) in western countries has been attributed to the HIV epidemic, immigration, and drug resistance. Multidrug resistant tuberculosis (MDR-TB) is caused by the transmission of multidrug resistant Mycobacterium tuberculosis strains in new cases, or by the selection of single drug resistant strains induced by previous treatment. The aim of this report is to determine risk factors for MDR-TB in Europe. Methods: A systematic review was conducted of published reports of risk factors associated with MDR-TB in Europe. Meta-analysis, meta-regression, and sub-grouping were used to pool risk estimates of MDR-TB and to analyse associations with age, sex, immigrant status, HIV status, occurrence year, study design, and area of Europe. Results: Twenty nine papers were eligible for the review from 123 identified in the search. The pooled risk of MDR-TB was 10.23 times higher in previously treated than in never treated cases, with wide heterogeneity between studies. Study design and geographical area were associated with MDR-TB risk estimates in previously treated patients; the risk estimates were higher in cohort studies carried out in western Europe (RR 12.63; 95% CI 8.20 to 19.45) than in eastern Europe (RR 8.53; 95% CI 6.57 to 11.06). National estimates were possible for six countries. MDR-TB cases were more likely to be foreign born (odds ratio (OR) 2.46; 95% CI 1.86 to 3.24), younger than 65 years (OR 2.53; 95% CI 1.74 to 4.83), male (OR 1.38; 95% CI 1.16 to 1.65), and HIV positive (OR 3.52; 95% CI 2.48 to 5.01). Conclusions: Previous treatment was the strongest determinant of MDR-TB in Europe. Detailed study of the reasons for inadequate treatment could improve control strategies. The risk of MDR-TB in foreign born people needs to be re-evaluated, taking into account any previous treatment.


Related Articles

  • Second-Line Drug Susceptibilities of Multidrug-Resistant Mycobacterium tuberculosis Isolates in Aegean Region - Turkey. Özkütük, Nuri; Sürücüoğlu, Süheyla; Gazı, Hörü; Coşkun, Meral; Özkütük, Aydan; Özbakkaloğlu, Beril // Turkish Journal of Medical Sciences;2008, Vol. 38 Issue 3, p245 

    Aim: The emergence of multidrug-resistant tuberculosis (MDR-TB) is increasing, and the standard short-course regimen used for the treatment of TB is likely to be ineffective against MDR-TB, leading to the need for second-line drugs. In such situations, drug susceptibility testing is necessary to...

  • Comparative growth pattern of multi drug resistance versus susceptible isolates of Mycobacterium tuberculosis in mice lungs. Dave, Sakshi; Faujdar, Jaya; Kumar, Praveen; Gupta, P.; Das, Ram; Parasher, Deepti; Chauhan, D. S.; Gupta, U. D.; Katoch, V. M.; Natrajan, M. // Indian Journal of Medical Research;Jul2009, Vol. 130 Issue 1, p58 

    Background & objectives: Rise in prevalence of multi-drug resistance (MDR) in tubercle bacilli is a serious cause of concern. As mutations with two house keeping genes rpoB and katG are associated with resistance to two important anti-tubercular drugs rifampicin and isoniazid respectively, there...

  • Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Jain, Amita; Mondal, Rajesh; Prasad, Rajendra; Singh, Kamlesh; Ahuja, R. C. // Indian Journal of Medical Research;Sep2008, Vol. 128 Issue 3, p300 

    Background & objectives: Multi-drug resistant (MDR) Mycobacterium tuberculosis isolates may be transmitted within communities due to dense population and poor hygienic conditions. For proper management and control of MDR-TB, understanding drug susceptibility pattern of M. tuberculosis isolates...

  • Extensively Drug-Resistant Tuberculosis (XDR-TB). Deresinski, Stan // Clinical Infectious Diseases;2/15/2007, Vol. 44 Issue 4, pvi 

    The article focuses on the study "Extensively Drug-Resistant Tuberculosis As a Cause of Death in Patients Co-Infected With Tuberculosis and HIV in a Rural Area of South Africa," by N.R. Gandhi, A. Moll, and A.W. Sturm. The study included 475 patients with culture-positive tuberculosis. 39% of...

  • Transmission of Drug-Resistant Tuberculosis among Treated Patients in Shanghai, China. Xia Li; Ying Zhang; Xin Shen; Guomiao Shen; Xiaohong Gui; Bin Sun; Jian Mei; DeRiemer, Kathryn; Small, Peter M.; Qian Gao // Journal of Infectious Diseases;3/15/2007, Vol. 195 Issue 6, p864 

    We sought to determine whether patients who had therapy failure with increasingly drug-resistant strains of tuberculosis had primary or acquired drug resistance, by genotyping the initial and subsequent drug-resistant clinical isolates of Mycobacterium tuberculosis collected from patients by the...

  • Rate and Amplification of Drug Resistance among Previously-Treated Patients with Tuberculosis in Kampala, Uganda. Temple, Beth; Ayakaka, Irene; Ogwang, Sam; Nabanjja, Helen; Kayes, Susan; Nakubulwa, Susan; Worodria, William; Levin, Jonathan; Joloba, Moses; Okwera, Alphonse; Eisenach, Kathleen D.; McNerney, Ruth; Elliott, Alison M.; Smith, Peter G.; Mugerwa, Roy D.; Ellner, Jerrold J.; Jones-López, Edward C. // Clinical Infectious Diseases;11/1/2008, Vol. 47 Issue 9, p1126 

    Background. Drug-resistant Mycobacterium tuberculosis has emerged as a global threat. In resource-constrained settings, patients with a history of tuberculosis (TB) treatment may have drug-resistant disease and may experience poor outcomes. There is a need to measure the extent of and risk...

  • The Evolution of Drug Resistance in Mycobacterium tuberculosis: From a Mono-Rifampin-Resistant Cluster into Increasingly Multidrug-Resistant Variants in an HIV-Seropositive Population. Bifani, Pablo; Mathema, Barun; Kurepina, Natalia; Shashkina, Elena; Bertout, Julie; Blanchis, Anne Sophie; Moghazeh, Soraya; Driscoll, Jeffrey; Gicquel, Brigitte; Frothingham, Richard; Kreiswirth, Barry N. // Journal of Infectious Diseases;7/1/2008, Vol. 198 Issue 1, p90 

    We describe the genotypic and phenotypic characteristics of a mono-rifampin-resistant (RIFR) Mycobacterium tuberculosis strain cluster (designated AU-RIFR) and the acquisition of additional drug resistance. Drug susceptibility, sequences of regions that determine drug resistance, and basic...

  • Transmission in the United States Virgin Islands and Florida of a Multidrug-Resistant Mycobacterium tuberculosis Strain Acquired in Puerto Rico. Reichler, Mary R.; Valway, Sarah E.; Onorato, Ida M. // Clinical Infectious Diseases;3/1/2000, Vol. 30 Issue 3, p617 

    Discusses the transmission in the United States Virgin Islands and Florida of a multidrug-resistant Mycobacterium tuberculosis strain acquired in Puerto Rico. Potential sources of M. tuberculosis transmission to the patient; Extent of transmission of the strain; Importance of maintaining an...

  • Human Tuberculosis due to Mycobacterium bovis in the United States, 1995-2005. Hlavsa, Michele C.; Moonan, Patrick K.; Cowan, Lauren S.; Navin, Thomas R.; Kammerer, J. Steve; Morlock, Glenn P.; Crawford, Jack T.; LoBue, Philip A. // Clinical Infectious Diseases;7/15/2008, Vol. 47 Issue 2, p168 

    Background. Understanding the epidemiology of human Mycobacterium bovis tuberculosis (TB) in the United States is imperative; this disease can be foodborne or airborne, and current US control strategies are focused on TB due to Mycobacterium tuberculosis and airborne transmission. The National...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics